JNJ - JOHNSON & JOHNSON
227.5
-3.150 -1.385%
Share volume: 5,689,219
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$230.65
-3.15
-0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-29-2024 | 12-29-2024 | 03-30-2025 | 06-29-2025 | 09-28-2025 | 12-28-2025 | 03-29-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 07-25-2024 | 10-23-2024 | 02-13-2025 | 04-23-2025 | 07-24-2025 | 10-22-2025 | 02-11-2026 | 04-22-2026 | |
| Assets | |||||||||
| Total Assets | 181.088 B | 178.287 B | 180.104 B | 193.671 B | 193.389 B | 192.816 B | 199.210 B | 200.894 B | |
| Current Assets | 57.817 B | 53.249 B | 55.893 B | 71.551 B | 54.498 B | 54.611 B | 55.624 B | 59.173 B | |
| Inventories | 12.169 B | 12.603 B | 12.444 B | 12.659 B | 13.412 B | 14.146 B | 14.191 B | 14.583 B | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 597.000 M | 317.000 M | 417.000 M | 307.000 M | 303.000 M | 331.000 M | 393.000 M | 363.000 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 24.878 B | 19.980 B | 24.105 B | 38.474 B | 18.577 B | 18.231 B | 19.709 B | 21.688 B | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 19.748 B | 20.479 B | 20.518 B | 20.871 B | 21.949 B | 22.338 B | 23.169 B | 23.270 B | |
| Other Assets | 103.523 B | 104.559 B | 103.693 B | 101.249 B | 116.942 B | 115.867 B | 120.417 B | 118.451 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 181.088 B | 178.287 B | 180.104 B | 193.671 B | 193.389 B | 192.816 B | 199.210 B | 200.894 B | |
| Total liabilities | 109.550 B | 108.129 B | 108.614 B | 115.562 B | 114.916 B | 113.539 B | 117.666 B | 119.708 B | |
| Total current liabilities | 53.933 B | 51.759 B | 50.321 B | 56.903 B | 54.180 B | 50.869 B | 54.126 B | 57.716 B | |
| Accounts Payable | 8.848 B | 8.954 B | 10.311 B | 9.545 B | 9.464 B | 9.625 B | 11.991 B | 10.460 B | |
| Other liabilities | 14.086 B | 14.923 B | 17.549 B | 10.435 B | 10.263 B | 9.926 B | 9.868 B | 10.208 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 31.636 B | 31.289 B | 30.651 B | 38.355 B | 39.235 B | 39.408 B | 39.438 B | 37.527 B | |
| Other liabilities | 14.086 B | 14.923 B | 17.549 B | 10.435 B | 10.263 B | 9.926 B | 9.868 B | 10.208 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 71.538 B | 70.158 B | 71.490 B | 78.109 B | 78.473 B | 79.277 B | 81.544 B | 81.186 B | |
| Common stock | 3.120 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | 3.120 B | |
| Retained earnings | 155.360 B | 155.179 B | 155.791 B | 162.635 B | 165.371 B | 167.281 B | 168.978 B | 169.161 B |